Demo Sign up Log In

Regeneron Pharmaceuticals (REGN)

Revenue

$16.90B

TTM · Period ending: Sep 30, 2026 · USD

REGN Revenue

Latest reported$16.90Bperiod endingSep 30, 2026

Latest reported$16.90Bperiod endingSep 30, 2026

REGN TTM Revenue ($5.00M → $16.90B)

TTM revenue

High-resolution chart · PNG

REGN revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Revenue — Trailing twelve months (TTM) (USD)
Period ending	Revenue (USD)
Sep 30, 2001	39,760,000
Jun 30, 2001	49,186,000
Mar 31, 2001	57,863,000
Dec 31, 2000	59,276,000
Sep 30, 2000	51,760,000
Jun 30, 2000	48,154,000
Mar 31, 2000	39,598,000
Dec 31, 1999	34,600,000
Sep 30, 1999	30,100,000
Jun 30, 1999	29,600,000
Mar 31, 1999	37,200,000
Dec 31, 1998	38,200,000
Sep 30, 1998	42,200,000
Jun 30, 1998	40,300,000
Mar 31, 1998	33,400,000
Dec 31, 1997	33,100,000
Sep 30, 1997	28,200,000
Jun 30, 1997	25,500,000
Mar 31, 1997	25,100,000
Dec 31, 1996	24,100,000
Sep 30, 1996	23,400,000
Jun 30, 1996	23,400,000
Mar 31, 1996	24,800,000
Dec 31, 1995	26,500,000
Sep 30, 1995	28,400,000
Jun 30, 1995	31,100,000
Mar 31, 1995	27,100,000
Dec 31, 1994	23,200,000
Sep 30, 1994	18,400,000
Jun 30, 1994	13,100,000
Mar 31, 1994	10,800,000
Dec 31, 1993	9,900,000
Sep 30, 1993	9,300,000
Jun 30, 1993	8,100,000
Mar 31, 1993	10,000,000
Dec 31, 1992	11,400,000
Sep 30, 1992	11,100,000
Jun 30, 1992	10,600,000
Mar 31, 1992	9,100,000
Dec 31, 1991	7,600,000
Sep 30, 1991	6,900,000
Jun 30, 1991	6,300,000
Mar 31, 1991	5,800,000
Dec 31, 1990	5,000,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.